SKP2 and neoplasm: A number of solid tumours including lung, breast, ovarian, prostate, colon and squamous cell carcinoma manifest conditions of high SKP2 accompanied by low p27KIP1considered to be associated with highly aggressive tumours [48,49,51–55].